Skip to main content

Table 1 Demographic data of the study population

From: Role of urinary NAG enzyme in early detection of renal impairment in cystic fibrosis patients

Variables

N=40 (100%)

Median (Max–Min)

Age in years

 

6 (12–2.5)

Age of presentation in months

 

5 (72–1.0)

Duration of disease in months

 

56 (12–108)

Duration of use of nephrotoxic drugs in months

 

28 (6–54)

Residence

 Urban

19 (47.5%)

 

 Rural

21 (52.5%)

 

Sex

 Male

24 (60%)

 

 Female

16(40%)

 

Positive consanguinity

18 (45%)

 

Positive family history with CF

10 (25%)